- Home
- EDTK vs IMNN Comparison
EDTK vs IMNN Comparison
Compare EDTK & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDTK
- IMNN
- Stock Information
- Founded
- EDTK 2013
- IMNN 1982
- Country
- EDTK China
- IMNN United States
- Employees
- EDTK N/A
- IMNN N/A
- Industry
- EDTK Other Consumer Services
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- EDTK Real Estate
- IMNN Health Care
- Exchange
- EDTK Nasdaq
- IMNN Nasdaq
- Market Cap
- EDTK 15.7M
- IMNN 13.6M
- IPO Year
- EDTK 2020
- IMNN 1985
- Fundamental
- Price
- EDTK $1.04
- IMNN $0.88
- Analyst Decision
- EDTK
- IMNN Strong Buy
- Analyst Count
- EDTK 0
- IMNN 2
- Target Price
- EDTK N/A
- IMNN $21.50
- AVG Volume (30 Days)
- EDTK 6.0K
- IMNN 115.3K
- Earning Date
- EDTK 05-02-2025
- IMNN 05-12-2025
- Dividend Yield
- EDTK N/A
- IMNN N/A
- EPS Growth
- EDTK N/A
- IMNN N/A
- EPS
- EDTK N/A
- IMNN N/A
- Revenue
- EDTK $624,365.00
- IMNN N/A
- Revenue This Year
- EDTK N/A
- IMNN N/A
- Revenue Next Year
- EDTK N/A
- IMNN N/A
- P/E Ratio
- EDTK N/A
- IMNN N/A
- Revenue Growth
- EDTK N/A
- IMNN N/A
- 52 Week Low
- EDTK $0.84
- IMNN $0.64
- 52 Week High
- EDTK $1.27
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- EDTK 57.61
- IMNN 45.55
- Support Level
- EDTK $0.94
- IMNN $0.82
- Resistance Level
- EDTK $1.06
- IMNN $0.98
- Average True Range (ATR)
- EDTK 0.05
- IMNN 0.06
- MACD
- EDTK 0.00
- IMNN -0.01
- Stochastic Oscillator
- EDTK 74.19
- IMNN 41.64
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.